Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
- PMID: 33933686
- PMCID: PMC8084632
- DOI: 10.1016/j.tmaid.2021.102078
Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
Conflict of interest statement
LSPM has consulted for/received speaker fees from bioMerieux (2013–2021), DNAelectronics (2015–18), Dairy Crest (2017–2018), Profile Pharma (2018), Umovis Lab (2020–2021), Eumedica (2016–2018), and Pfizer (2018–2021), received research grants from the National Institute for Health Research (2013–2019), and CW+ Charity (2018–2021). NM has received speaker fees from Beyer (2016) and Pfizer (2019) and received educational support from Eumedica (2016) and Baxter (2017). RJ has received honoraria, speaker fees, travel support and/or research grant funding from Gilead, ViiV Healthcare, BMS, Abbvie, Janssen and Merck. SJCP has received a research grant from the Scientific Exploration Society. All other authors have no conflicts of interest to declare.
Comment on
-
Testing Dilemmas: Post negative, positive SARS-CoV-2 RT-PCR - is it a reinfection?Travel Med Infect Dis. 2020 May-Jun;35:101743. doi: 10.1016/j.tmaid.2020.101743. Epub 2020 May 15. Travel Med Infect Dis. 2020. PMID: 32416153 Free PMC article. No abstract available.
References
-
- Public Health England . 13 Feb 2021. Investigation of SARS-CoV-2 variants of concern in England: technical briefing 6.https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
-
- Pallett S.J.C., Rayment M., Patel A., Fitzgerald-Smith S.A.M., Denny S.J., Charani E., et al. Point-of-care serological assays for delayed SARS-CoV-2 case identification among UK healthcare workers: a prospective multi-centre cohort study. Lancet Resp. Med. 2020;8(9):885–894. doi: 10.1016/S2213-2600(20)30315-5. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous